Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Haemacure has raised $7.8 million through the exercise of amended series B warrants and broker warrants issued as part of the private placement concluded in January 2007.
Subscribe to our email newsletter
Joseph Galli, chairman and CEO of Haemacure, said: “We now have the financial resources to execute on all of the necessary milestones to get our fibrin sealant into the clinic in the first quarter of 2009.
This financing significantly reduces the financial risk. All of our time and attention will be focused on execution and getting a green light from the FDA to enter clinical trials.”